发明名称 |
cristal, droga, e, uso de um cristal |
摘要 |
The present invention relates to a crystal of 1-ethyl-7-methyl-3-{4-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)oxy]phenyl}-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one useful as a prophylactic or therapeutic agent for schizophrenia and the like, which shows an X-ray powder diffraction pattern having characteristic peaks at interplaner spacings (d) of 13.59 plus or minus 0.2 and 6.76 plus or minus 0.2 Angstroms in powder X-ray diffraction. |
申请公布号 |
BR112013032052(A2) |
申请公布日期 |
2016.12.13 |
申请号 |
BR20131132052 |
申请日期 |
2012.06.21 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
KATSUHIKO YAMAMOTO |
分类号 |
C07D471/04;A61K31/437;A61P25/18 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|